N-acetyl-cysteine is associated to renal function improvement in patients with nephropathic cystinosis

Pediatric Nephrology

Volumn 29, Issue 6, 2014, Pages 1097-1102

  Pache De Faria Guimaraes, Luciana ^a   Seguro, Antonio Carlos ^a   Shimizu, Maria Heloisa Mazzola ^a   Lopes Neri, Letícia Aparecida ^a   Sumita, Nairo Massakasu ^a   De Bragança, Ana Carolina ^a   Aparecido Volpini, Rildo ^a   Cunha Sanches, Talita Rojas ^a   Macaferri Da Fonseca, Fernanda Andrade ^a   Moreira Filho, Carlos Alberto ^a   Vaisbich, Maria Helena ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Department of Nephrology Hospital Das Clínicas Universidade de São Paulo ^*  (Brazil)

Author keywords

Cysteamine; Glomerular filtration rate; N Acetylcysteine; Nephropathic cystinosis; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; CREATININE; CYSTATIN C; GLUTATHIONE; MERCAPTAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ANTIOXIDANT; CYSTINE DEPLETING AGENT;

ABSENCE OF SIDE EFFECTS; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYSTINOSIS; CYTOSOL; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; NEPHROPATHIC CYSTINOSIS; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TREATMENT DURATION; CLINICAL TRIAL; DRUG EFFECTS; KIDNEY FUNCTION TEST;

ACETYLCYSTEINE; ANTIOXIDANTS; CHILD; CYSTEAMINE; CYSTINE DEPLETING AGENTS; CYSTINOSIS; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; MALE; OXIDATIVE STRESS;

EID: 84901587201     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2705-3     Document Type: Article

References (26)

1. Gahl WA, Tietze F, Bashan W (1982) Defective cystic exodus from isolated lysosome-rich fractions of cystinotic leukocytes. J Biol Hem 257(16):9570-9575
2. Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF,Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C (1998) A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18(4):319-324
3. Vaisbich MH, Koch VH, The Brazilian Cystinosis Study Group (2010) Report of a Brazilian multicenter study on nephropathic cystinosis. Nephron Clin Pract 114:c12-c18
4. Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, Charbit M, Moyse D, Legendre C, Lesavre P, Cochat P, Servais A (2012) Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int 81: 179-189
5. Gahl WA, Balog JZ, Kleta R (2007) Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Int Med 147:242-250
6. Greco M, BrugnaraM, Zaffanello M, Taranta A, Pastore A, Emma F (2010) Long-term outcome of nephropathic cystinosis: a 20-year single-center experience. Pediatr Nephrol 25:2459-2467
7. Wilmer MJ, de Graaf-Hess A, Blom HJ, Dijkman HB,Monnens LA, van den Heuvel LP, Levtchenko EN (2005) Elevated oxidized glutathione in cystinotic proximal tubular epithelial cells. Biochem Biophysl Res Commun 337:610-614
8. Sansanwal P, Yen B, Gahl WA, Ma Y, Ying L, Wong LJ, Sarwal MM (2010) Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol 21:272-283
9. Wilmer MJ, Emma F, Levtchenko EN (2010) The pathogenesis of cystinosis: mechanisms beyond cystine accumulation. Am J Physiol Renal Physiol 299:F905-F916
10. Levtchenko E, de Graaf-Hess A, Wilmer M, van den Heuvel L, Monnens L, Blom H (2005) Altered status of glutathione and its metabolites in cystinotic cells. Nephrol Dial Transplant 20:1828-1832
11. Vitvitsky V, Witcher M, Banerjee R, Thoene J (2010) The redox status of cystinotic fibroblasts. Mol Genet Metabol 99:384-388
12. Vaisbich MH, Guimaraes LPF, Shimizu MHM, Seguro AC (2011) Oxidative stress in cystinosis patients. Nephron Extra 1:73-77
13. Hanly LN, Chen N, Aleksa K, Cutler M, Bajcetic M, Palassery R, Regueira O, Turner C, Baw B, Malkin B, Freeman D, Rieder MJ, Vasylyeva TL, Koren G (2012) N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children: translational pharmacokinetics. J Clin Pharmacol 52(1):55-64
14. Duru M, Nacar A, Yönden Z, Kuvandik G, Helvaci MR, Koç A, Akaydin Y, Oksüz H, Söǧüt S (2008) Protective effects of N-acetylcysteine on cyclosporine-A-induced nephrotoxicity. Ren Fail 30:453-459
15. Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A (2008) The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant 23: 2198-2205
16. Drager LF, Andrade L, Toledo JFB, Laurindo FRM, Cesar LAM, Seguro AC(2004) Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant 19:1803-1807
17. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416-1421
18. Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832-1843
19. Shimizu MHM, Coimbra TM, Araujo M, Menezes LF, Seguro AC (2005) N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int 68:2208-2217
20. Danilovic A, Lucon AM, Srougi M, Shimizu MH, Ianhez LE, Nahas WC, Seguro AC (2011) Protective effect of N-acetylcysteine on early outcomes of deceased renal transplantation. Transplant Proc 43(5): 1443-1449
21. Dohil R, FidlerM, Gangoiti JA, Kaskel F, Schneider JA, Barshop BA (2010) Twice-daily cysteamine bitartrate therapy for children with cystinosis. J Pediatr 156(1):71-75, e3
22. Yeagy BA, Harrison F, Gubler MC, Koziol JA, Salomon DR, Cherqui S (2011) Kidney preservation by bone marrow cell transplantation in hereditary nephropathy. Kidney Int 79(11): 1198-1206
23. Wilmer MJ, Kluijtmans LA, van der Velden TJ, Willems PH, Scheffer PG, Masereeuw R, Monnens LA, van den Heuvel LP, Levtchenko EN (2011) Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells. Biochim Biophys Acta 1812:643-651
24. Aruoma OI, Halliwell B, Hoey BM (1989) The antioxidant action of N-acetylcysteine: its action with hydrogen peroxide, hydroxyl radical, superoxide and hipochlorous acid. Free Radic Biol Med 6:593
25. Ruiz Fuentes MC, Moreno Ayuso JM, Ruiz Fuentes N, Vargas Palomares JF, Asensio Peinado C, Osuna Ortega A (2008) Treatment with N-acetylcysteine in stable renal transplantation. Transplant Proc 40:2897-2899
26. Guimarães LPF, Neri LAL, Sumita NM, Vaisbich MH (2011) Practical markers of renal function among patients with cystinosis. J Bras Nefrol 33(3):1-4